PPP2CA and ovarian carcinoma: Luteolin can be used to treat prostate cancer (JPRN-jRCTs041230029), and inhibit ovarian cancer stem cells proliferation by interfering with the KDM4C/PPP2CA/YAP pathway (ChiCTR2200056567).